Literature DB >> 16272479

Evaluation of enzyme-linked immunosorbent assays, an immunofluorescent-antibody test, and two rapid tests (immunochromatographic-dipstick and gel tests) for serological diagnosis of symptomatic and asymptomatic Leishmania infections in dogs.

Maik Mettler1, Felix Grimm, Gioia Capelli, Heinrich Camp, Peter Deplazes.   

Abstract

Enzyme-linked immunosorbent assays (ELISAs) based on soluble antigens derived from promastigote or amastigote-like stages of Leishmania infantum and on the recombinant rK39 antigen, each in combination with different conjugates [anti-immunoglobulin G1 [IgG1], anti-IgG2, anti-IgG(gamma), and anti-IgG heavy plus light chains], were compared to an immunofluorescent-antibody test (IFAT) and two commercially available rapid test systems (DiaMed-Vet-IT Leish and ID-PaGIA canine leishmaniasis antibody test) for the detection of specific anti-Leishmania antibodies in symptomatic and asymptomatic dogs with proven L. infantum infections. ELISAs based on soluble promastigote and amastigote antigens had very high sensitivities in symptomatic (n = 30; 100%) and asymptomatic dogs (n = 17; 94.1 to 100%), except when combined with the anti-IgG1 conjugate (41.2 to 82.4%). Specificities were high for all combinations (n = 50; 96 to 100%). The rK39 ELISA detected fewer asymptomatic cases (sensitivities, 52.9 to 64.7%) but was highly specific (96 to 100%). The IFAT was 90% sensitive in symptomatic dogs but was significantly less sensitive in asymptomatic cases (29.4%). However, it had an excellent specificity (100%). Test performances of the rapid tests based on the rK39 antigen were comparable to the ELISAs based on the same antigen. ELISAs based on soluble promastigote or amastigote antigens seem to be most suited for the serological diagnosis of canine Leishmania infections in both symptomatic and asymptomatic dogs. IFAT and the rK39 ELISA lack sensitivity in asymptomatic cases but are highly specific. Rapid tests like the rK39 dipstick test or the ID-PaGIA are helpful for confirming clinically suspected cases because of their high specificities in symptomatic animals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16272479      PMCID: PMC1287801          DOI: 10.1128/JCM.43.11.5515-5519.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  Visceral leishmaniasis in a New York foxhound kennel.

Authors:  Amanda A Gaskin; Peter Schantz; Joan Jackson; Adam Birkenheuer; Lindsay Tomlinson; Marina Gramiccia; Michael Levy; Frank Steurer; Eleanor Kollmar; Barbara C Hegarty; Albert Ahn; Edward B Breitschwerdt
Journal:  J Vet Intern Med       Date:  2002 Jan-Feb       Impact factor: 3.333

2.  A comparison of the effects of a benzimidazole and the dinitroanilines against Leishmania infantum.

Authors:  A Armson; S W Kamau; F Grimm; J A Reynoldson; W M Best; L M MacDonald; R C Thompson
Journal:  Acta Trop       Date:  1999-10-15       Impact factor: 3.112

3.  A cross-sectional study of Leishmania spp. infection in clinically healthy dogs with polymerase chain reaction and serology in Greece.

Authors:  Leonidas S Leontides; Manolis N Saridomichelakis; Charalambos Billinis; Vasilios Kontos; Alexander F Koutinas; Apostolos D Galatos; Mathios E Mylonakis
Journal:  Vet Parasitol       Date:  2002-10-16       Impact factor: 2.738

4.  Immune response against Leishmania antigens in dogs naturally and experimentally infected with Leishmania infantum.

Authors:  A Rhalem; H Sahibi; N Guessous-Idrissi; S Lasri; A Natami; M Riyad; B Berrag
Journal:  Vet Parasitol       Date:  1999-03-01       Impact factor: 2.738

Review 5.  Canine leishmaniasis.

Authors:  Jorge Alvar; Carmen Cañavate; Ricardo Molina; Javier Moreno; Javier Nieto
Journal:  Adv Parasitol       Date:  2004       Impact factor: 3.870

6.  Infectious diseases. Has leishmaniasis become endemic in the U.S.?

Authors:  M Enserink
Journal:  Science       Date:  2000-12-08       Impact factor: 47.728

7.  Evaluation of the Leishmania recombinant K39 antigen as a diagnostic marker for canine leishmaniasis and validation of a standardized enzyme-linked immunosorbent assay.

Authors:  A Scalone; R De Luna; G Oliva; L Baldi; G Satta; G Vesco; W Mignone; C Turilli; R R Mondesire; D Simpson; A R Donoghue; G R Frank; L Gradoni
Journal:  Vet Parasitol       Date:  2002-04-02       Impact factor: 2.738

8.  Leishmaniasis in Tuscany (Italy): VI. Canine leishmaniasis in the focus of Monte Argentario (Grosseto).

Authors:  E Pozio; L Gradoni; S Bettini; M Gramiccia
Journal:  Acta Trop       Date:  1981-12       Impact factor: 3.112

9.  Rapid immunochromatographic test for serodiagnosis of canine leishmaniasis.

Authors:  D Otranto; P Paradies; M Sasanelli; R Spinelli; O Brandonisio
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

10.  Rapid detection of Leishmania infantum infection in dogs: comparative study using an immunochromatographic dipstick test, enzyme-linked immunosorbent assay, and PCR.

Authors:  Richard Reithinger; Rupert J Quinnell; Bruce Alexander; Clive R Davies
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

View more
  56 in total

1.  Characterization of novel Leishmania infantum recombinant proteins encoded by genes from five families with distinct capacities for serodiagnosis of canine and human visceral leishmaniasis.

Authors:  Geraldo G S Oliveira; Franklin B Magalhães; Márcia C A Teixeira; Andrea M Pereira; Cristiane G M Pinheiro; Lenita R Santos; Marília B Nascimento; Cheila N G Bedor; Alessandra L Albuquerque; Washington L C dos-Santos; Yara M Gomes; Edson D Moreira; Maria E F Brito; Lain C Pontes de Carvalho; Osvaldo P de Melo Neto
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Utility of the microculture method in non-invasive samples obtained from an experimental murine model with asymptomatic leishmaniasis.

Authors:  Adil M Allahverdiyev; Malahat Bagirova; Rabia Cakir-Koc; Serhat Elcicek; Olga Nehir Oztel; Sezen Canim-Ates; Emrah Sefik Abamor; Serap Yesilkir-Baydar
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

3.  Current Surveys of the Seroprevalence of Borrelia burgdorferi, Ehrlichia canis, Anaplasma phagocytophilum, Leishmania infantum, Babesia canis, Angiostrongylus vasorum and Dirofilaria immitis in Dogs in Bulgaria.

Authors:  Nikola Pantchev; Manuela Schnyder; Majda Globokar Vrhovec; Roland Schaper; Ilia Tsachev
Journal:  Parasitol Res       Date:  2015-08       Impact factor: 2.289

4.  Semi-quantitative measurement of asymptomatic L. infantum infection and symptomatic visceral leishmaniasis in dogs using Dual-Path Platform® CVL.

Authors:  Mandy Larson; Angela Toepp; Benjamin Scott; Melissa Kurtz; Hailie Fowler; Javan Esfandiari; Randall F Howard; Aarthy C Vallur; Malcolm S Duthie; Christine Petersen
Journal:  Appl Microbiol Biotechnol       Date:  2016-10-31       Impact factor: 4.813

5.  Subtractive phage display selection from canine visceral leishmaniasis identifies novel epitopes that mimic Leishmania infantum antigens with potential serodiagnosis applications.

Authors:  Lourena E Costa; Mayara I S Lima; Miguel A Chávez-Fumagalli; Daniel Menezes-Souza; Vivian T Martins; Mariana C Duarte; Paula S Lage; Eliane G P Lopes; Daniela P Lage; Tatiana G Ribeiro; Pedro H R Andrade; Danielle F de Magalhães-Soares; Manuel Soto; Carlos A P Tavares; Luiz R Goulart; Eduardo A F Coelho
Journal:  Clin Vaccine Immunol       Date:  2013-11-20

6.  Serological diagnosis of canine leishmaniosis: comparison of three commercially available tests.

Authors:  Denis Wolf; Klaus Failing; Anja Taubert; Nikola Pantchev
Journal:  Parasitol Res       Date:  2014-04-10       Impact factor: 2.289

7.  Detection of Trypanosoma cruzi infection in naturally infected dogs and cats using serological, parasitological and molecular methods.

Authors:  G F Enriquez; M V Cardinal; M M Orozco; A G Schijman; R E Gürtler
Journal:  Acta Trop       Date:  2013-03-13       Impact factor: 3.112

8.  Epitope mapping of the HSP83.1 protein of Leishmania braziliensis discloses novel targets for immunodiagnosis of tegumentary and visceral clinical forms of leishmaniasis.

Authors:  Daniel Menezes-Souza; Tiago Antônio de Oliveira Mendes; Matheus de Souza Gomes; João Luís Reis-Cunha; Ronaldo Alves Pinto Nagem; Cláudia Martins Carneiro; Eduardo Antônio Ferraz Coelho; Lúcia Maria da Cunha Galvão; Ricardo Toshio Fujiwara; Daniella Castanheira Bartholomeu
Journal:  Clin Vaccine Immunol       Date:  2014-05-07

9.  Detection of cross infections by Leishmania spp. and Trypanosoma spp. in dogs using indirect immunoenzyme assay, indirect fluorescent antibody test and polymerase chain reaction.

Authors:  M A Viol; V M F Lima; M C C Aquino; G Gallo; I P Alves; D Generoso; S H V Perri; S B Lucheis; H Langoni; C M Nunes; K D S Bresciani
Journal:  Parasitol Res       Date:  2012-07-31       Impact factor: 2.289

10.  Sensitive and specific serodiagnosis of Leishmania infantum infection in dogs by using peptides selected from hypothetical proteins identified by an immunoproteomic approach.

Authors:  Miguel A Chávez-Fumagalli; Vivian T Martins; Miriam C S Testasicca; Daniela P Lage; Lourena E Costa; Paula S Lage; Mariana C Duarte; Henrique G Ker; Tatiana G Ribeiro; Fernando A A Carvalho; Wiliam C B Régis; Alexandre B Dos Reis; Carlos A P Tavares; Manuel Soto; Ana Paula Fernandes; Eduardo A F Coelho
Journal:  Clin Vaccine Immunol       Date:  2013-04-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.